Dian Diagnostics

Forecast & Rating7 analysts currently cover Dian Diagnostics, with about 42.9% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥19.99, about 1.8% downside from the current price of ¥20.35. Price targets range from ¥14.00 to ¥24.46 — a wide spread, showing clear disagreement over just how much Dian Diagnostics can rise. Historically, about 18.0% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Dian Diagnostics are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Oct 23, 2026; for reference only and not investment advice.